Bictegravir
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Bictegravir and local guidelines before prescribing.
Integrase inhibitor
Mechanism
Integrase strand transfer inhibitor (fixed-dose with emtricitabine and tenofovir alafenamide).
Uses
HIV infection.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Headache, diarrhoea, nausea, weight gain.
Interactions
Polyvalent cations reduce absorption; rifampicin contraindicated; metformin.
Contraindications and cautions
Rifampicin use
Monitoring
HIV viral load, renal function
Pregnancy and breastfeeding
Used in pregnancy
Renal and hepatic impairment
Avoid if CrCl below 30
Overdose and reversal
Supportive
Special advice
Hepatitis B flare on stopping.
More from the textbook: uses, cautions and other points
- Integrase inhibitors | Dolutegravir , bictegravir , raltegravir, cabotegravir | Well tolerated; insomnia, headache, weight gain ; dolutegravir and bictegravir raise creatinine slightly (block its secretion - not true kidney damage); absorption reduced by antacids, calcium, iron, magnesium - separate doses
ID: HIV, viral hepatitis and blood-borne viruses - Bictegravir–emtricitabine–tenofovir alafenamide | Common single-tablet HIV regimen; separate from antacids, iron, calcium; slight creatinine rise.
ID: HIV, viral hepatitis and blood-borne viruses - Integration | Integrase inhibitors ( dolutegravir , bictegravir, cabotegravir) | HIV
Microbiology: Virology - structure, replication and important viral infections - Antiretroviral therapy (ART) - start at diagnosis regardless of CD4 count (usually two NRTIs plus an integrase inhibitor, e.g. bictegravir/emtricitabine/tenofovir alafenamide; long-acting injectable cabotegravir + rilpivirine every 2 months for suppressed patients). Check HLA-B*57:01 before abacavir.
Microbiology: Virology - structure, replication and important viral infections